Your browser doesn't support javascript.
loading
SARS-CoV-2 Omicron variant escapes neutralizing antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescents.
Garcia-Valtanen, Pablo; Hope, Christopher M; Masavuli, Makutiro G; Yeow, Arthur Eng Lip; Balachandran, Harikrishnan; Mekonnen, Zelalem A; Al-Delfi, Zahraa; Abayasingam, Arunasingam; Agapiou, David; Stella, Alberto Ospina; Aggarwal, Anupriya; Bouras, George; Gummow, Jason; Ferguson, Catherine; O'Connor, Stephanie; McCartney, Erin M; Lynn, David J; Maddern, Guy; Gowans, Eric J; Reddi, Benjamin A J; Shaw, David; Kok-Lim, Chuan; Beard, Michael R; Weiskopf, Daniela; Sette, Alessandro; Turville, Stuart G; Bull, Rowena A; Barry, Simon C; Grubor-Bauk, Branka.
Afiliação
  • Garcia-Valtanen P; Viral Immunology Group, Adelaide Medical School, University of Adelaide and Basil Hetzel Institute for Translational Health Research, Adelaide, SA, Australia.
  • Hope CM; Molecular Immunology, Robinson Research Institute, University of Adelaide, Adelaide, SA, Australia; Women's and Children's Health Network, North Adelaide, SA, Australia.
  • Masavuli MG; Viral Immunology Group, Adelaide Medical School, University of Adelaide and Basil Hetzel Institute for Translational Health Research, Adelaide, SA, Australia.
  • Yeow AEL; Viral Immunology Group, Adelaide Medical School, University of Adelaide and Basil Hetzel Institute for Translational Health Research, Adelaide, SA, Australia.
  • Balachandran H; School of Medical Sciences, Faculty of Medicine, UNSW, Australia, Sydney, NSW, Australia.
  • Mekonnen ZA; Viral Immunology Group, Adelaide Medical School, University of Adelaide and Basil Hetzel Institute for Translational Health Research, Adelaide, SA, Australia.
  • Al-Delfi Z; Viral Immunology Group, Adelaide Medical School, University of Adelaide and Basil Hetzel Institute for Translational Health Research, Adelaide, SA, Australia.
  • Abayasingam A; School of Medical Sciences, Faculty of Medicine, UNSW, Australia, Sydney, NSW, Australia.
  • Agapiou D; School of Medical Sciences, Faculty of Medicine, UNSW, Australia, Sydney, NSW, Australia.
  • Stella AO; The Kirby Institute, The University of New South Wales, Sydney, NSW, Australia.
  • Aggarwal A; The Kirby Institute, The University of New South Wales, Sydney, NSW, Australia.
  • Bouras G; Adelaide Medical School, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia; The Department of Surgery - Otolaryngology, Head and Neck Surgery, University of Adelaide and the Basil Hetzel Institute for Translational Health Research, Central Adelaide Local Hea
  • Gummow J; Gene Silencing and Expression Core Facility, Adelaide Health and Medical Sciences, Robinson Research Institute, University of Adelaide, Adelaide, SA, Australia.
  • Ferguson C; Infectious Diseases Department, Royal Adelaide Hospital, Central Adelaide Local Health Network, Adelaide, SA, Australia.
  • O'Connor S; Intensive Care Unit, Royal Adelaide Hospital, Central Adelaide Local Health Network and Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia.
  • McCartney EM; Infectious Diseases Department, Royal Adelaide Hospital, Central Adelaide Local Health Network, Adelaide, SA, Australia.
  • Lynn DJ; Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA 5001, Australia; Flinders Health and Medical Research Institute, Flinders University, Bedford Park, SA 5042, Australia.
  • Maddern G; Discipline of Surgery, The University of Adelaide, Adelaide, SA 5000, Australia.
  • Gowans EJ; Viral Immunology Group, Adelaide Medical School, University of Adelaide and Basil Hetzel Institute for Translational Health Research, Adelaide, SA, Australia.
  • Reddi BAJ; Intensive Care Unit, Royal Adelaide Hospital, Central Adelaide Local Health Network and Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia.
  • Shaw D; Infectious Diseases Department, Royal Adelaide Hospital, Central Adelaide Local Health Network, Adelaide, SA, Australia.
  • Kok-Lim C; Gene Silencing and Expression Core Facility, Adelaide Health and Medical Sciences, Robinson Research Institute, University of Adelaide, Adelaide, SA, Australia; Microbiology and Infectious Diseases Department, SA Pathology, Adelaide, SA, Australia; Research Centre for Infectious Diseases, School of
  • Beard MR; Research Centre for Infectious Diseases, School of Biological Sciences, The University of Adelaide, Adelaide, SA, Australia.
  • Weiskopf D; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA, USA.
  • Sette A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA, USA; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego (UCSD), La Jolla, CA, USA.
  • Turville SG; The Kirby Institute, The University of New South Wales, Sydney, NSW, Australia.
  • Bull RA; School of Medical Sciences, Faculty of Medicine, UNSW, Australia, Sydney, NSW, Australia.
  • Barry SC; Molecular Immunology, Robinson Research Institute, University of Adelaide, Adelaide, SA, Australia; Women's and Children's Health Network, North Adelaide, SA, Australia. Electronic address: simon.barry@adelaide.edu.au.
  • Grubor-Bauk B; Viral Immunology Group, Adelaide Medical School, University of Adelaide and Basil Hetzel Institute for Translational Health Research, Adelaide, SA, Australia. Electronic address: branka.grubor@adelaide.edu.au.
Cell Rep Med ; 3(6): 100651, 2022 06 21.
Article em En | MEDLINE | ID: mdl-35654046
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / COVID-19 Limite: Humans Idioma: En Revista: Cell Rep Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / COVID-19 Limite: Humans Idioma: En Revista: Cell Rep Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália